Home>>Signaling Pathways>> Metabolism>> Reproductive Biology>>(+)-Cloprostenol isopropyl ester

(+)-Cloprostenol isopropyl ester (Synonyms: (+)-5-cis Cloprostenol isopropyl ester, (+)16mchlorophenoxy tetranor Prostaglandin F2α isopropyl ester)

Catalog No.GC45260

(+)-Cloprostenol is a synthetic analog of prostaglandin F2α (PGF2α).

Products are for research use only. Not for human use. We do not sell to patients.

(+)-Cloprostenol isopropyl ester Chemical Structure

Cas No.: 157283-66-4

Size Price Stock Qty
1mg
$100.00
In stock
5mg
$448.00
In stock
10mg
$795.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

(+)-Cloprostenol is a synthetic analog of prostaglandin F2α (PGF2α). It is an FP receptor agonist and a potent luteolytic agent in rats and hamsters. (+)-Cloprostenol is the optically active, 15(R) enantiomer of cloprostenol responsible for the majority of its biological activity. It is 200 times more potent than PGF2α in terminating pregnancy when given subcutaneously at a daily dose of 0.125 μg/kg in rats and hamsters, without the side effects associated with PGF2α. (+)-Cloprostenol was also shown to be a potent inhibitor of rat adipose precursor differentiation in primary cultures with an IC50 value of 3 x 10-12 M. (+)-Cloprostenol isopropyl ester is a more lipid soluble form of cloprostenol.

Reviews

Review for (+)-Cloprostenol isopropyl ester

Average Rating: 5 ★★★★★ (Based on Reviews and 12 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for (+)-Cloprostenol isopropyl ester

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.